Craighead, WE, Dunlop, BW. Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how. Annu Rev Psychol. 2014;65: 267–300.
Cuijpers, P, van Straten, A, Warmerdam, L, et al. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26(3): 279–288.
Duman, RS, Aghajanian, GK, Sanacora, G,et al. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3): 238–249.
Costi, S, Soleimani, L, Glasgow, A, et al. Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial. Neuropsychopharmacology. 2019. Epub ahead of print.
Krystal, JH, Abdallah, CG, Sanacora, G, et al. Ketamine: a paradigm shift for depression research and treatment. Neuron. 2019;101(5): 774–778.
Thomas, RK, Baker, G, Lind, J,et al. Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness. J Psychopharmacol. 2018;32(10): 1110–1117.
Ballard, ED,Wills, K, Lally, N, et al. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. J Affect Disord. 2017;218: 195–200.
Lopresti, AL. Cognitive behaviour therapy and inflammation: a systematic review of its relationship and the potential implications for the treatment of depression. Aust N Z J Psychiatry. 2017;51(6): 565–582.
Hasler, G, Drevets, WC, Manji, HK,et al. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004;29(10): 1765–1781.
Yang, Y, Cui, Y, Sang, K, et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature. 2018;554(7692): 317–322.
Fattore, L, Piva, A, Zanda, MT, et al. Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine. Psychopharmacology (Berl). 2018;235(2): 433–445.
MacLean, KA, Johnson, MW, Griffiths, RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol. 2011;25(11): 1453–1461.
Rogers, CR. The concept of the fully functioning person. Psychother Theory Res Pract. 1963;1(1): 17–26.
Stocker, K, Hasler, G, Hartmann, M. The altered-state-of-consciousness aspect of a feeling of lightness is reported to be associated with antidepressant benefits by depressed individuals receiving ketamine infusions: a systematic analysis of Internet video testimonials. Psychother Psychosom. 2019:1–2. Epub ahead of print.
Kupferberg, A, Bicks, L, Hasler, G. Social functioning in major depressive disorder. Neurosci Biobehav Rev. 2016;69: 313–332.